Skip to Content

R717 (Lamotrigine Extended-Release 25 mg)

Pill with imprint R717 is Yellow, Round and has been identified as Lamotrigine Extended-Release 25 mg. It is supplied by Dr. Reddy's Laboratories, Inc..

Lamotrigine is used in the treatment of bipolar disorder; schizoaffective disorder; seizure prevention; epilepsy and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for R717

Lamotrigine extended-release 25 mg R717

Lamotrigine Extended-Release

Imprint
R717
Strength
25 mg
Color
Yellow
Shape
Round
Availability
Prescription only
Drug Class
Triazine anticonvulsants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Dr. Reddy's Laboratories, Inc.
National Drug Code (NDC)
55111-0717

Get help with Imprint Code FAQs.

Related Images for "R717"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.